Part I Overview We are a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer. We develop and commercialize innovative solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Our entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. We found...
Q2 FY2026 — expected 2026-08-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-03 | 2025-12-31 | 0002019410-26-000016 | EDGAR | 114K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-05 | 2025-09-30 | 0002019410-25-000028 | EDGAR | 93K words |
| 2025-08-12 | 2025-06-30 | 0002019410-25-000012 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-02 | 0002019410-26-000019 | EDGAR | 1K words |
| 2026-02-26 | 0002019410-26-000011 | EDGAR | — |
| 2026-01-12 | 0002019410-26-000005 | EDGAR | — |
| 2025-11-05 | 0002019410-25-000026 | EDGAR | — |
| 2025-10-30 | 0002019410-25-000020 | EDGAR | — |
| 2025-08-12 | 0002019410-25-000011 | EDGAR | — |
| 2025-06-20 | 0001104659-25-061148 | EDGAR | — |
13 total filings indexed. 3 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0002019410 |
| Ticker | CAI |
| Exchange | Nasdaq |
| SIC | 8071: Services-Medical Laboratories |
| Incorporated | TX |
| Website | https://www.carislifesciences.com |
| Listed | 2025-06-18 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report